Skip to main content
SpringerLink
Log in

Alemtuzumab

Paroxysmal nocturnal haemoglobinuria and subsequent intracranial thrombosis: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Cheng KL, Brody J, Warshall CE, Sloand EM, Allen SL.Paroxysmal nocturnal hemoglobinuria following alemtuzumab immunosuppressive therapy for myelodysplastic syndrome and complicated by recurrent life-threatening thrombosis despite anticoagulation: successful intervention with eculizumab and fondaparinux. Leukemia Research 34: e85-e87, No. 4, Apr 2010. Available from: URL: http://dx.doi.org/10.1016/j.leukres.2009.09.024 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alemtuzumab. React. Wkly. 1300, 6 (2010). https://doi.org/10.2165/00128415-201013000-00015

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013000-00015

Keywords

Search

Navigation